TECHMATRIX CORPORATION [3762.T]
TOKYO, Apr 24 (Pulse News Wire) – TechMatrix Corporation (3762.T) announced today that it has reached an agreement with MedDomain Co., Ltd. to acquire all shares of MedDomain except those held by its CEO, Iizuka Toshio, for approximately ¥2.300 billion.
As a result, MedDomain is expected to become a consolidated subsidiary of TechMatrix. Previously, on February 17, 2026, TechMatrix and its wholly-owned subsidiary PSP Corporation had disclosed their intention to acquire MedDomain's shares. Today’s acquisition includes ordinary shares totaling ¥842.7 billion, S-type preferred shares amounting to ¥1.41 trillion, and A-type preferred shares of 22,867, representing a total of 45,371 voting rights and a holding ratio of 29.10%.
Additionally, PSP Corporation will hold ordinary shares of ¥1.27 trillion, S-type preferred shares of ¥1.99 trillion, and A-type preferred shares of 34,375, with a combined voting power of 66,977 and a holding ratio of 42.95%. The transaction is scheduled to be finalized on April 30, 2026, with the share transfer agreements signed. The initial plan outlined on February 17, 2026, included basic agreement signing on February 17, 2026 and anticipated share transfer completion by the end of April 2026.
However, the final execution dates will vary based on individual shareholder arrangements.
🟢 Confidence: High AI-translated content.